Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell World Chess (CHSS) by Steve Moore in ShareProphets
- Avoid Trifast (TRI) by Steve Moore in ShareProphets
- Avoid The Magnum Ice Cream Company (MICC) by Steve Moore in ShareProphets
- Buy Relx plc (REL) by Bank of America
- Buy South32 Limited (DI) (S32) by UBS
- Buy Weir Group (WEIR) by UBS
- Buy Relx plc (REL) by UBS
- Avoid Iomart Group (IOM) by Steve Moore in ShareProphets
- Buy Halma (HLMA) by Goldman Sachs
- Sell Ashmore Group (ASHM) by Deutsche Bank
- Hold Mondi (MNDI) by Deutsche Bank
- Hold Schroders (SDR) by Deutsche Bank
- Buy Relx plc (REL) by Deutsche Bank
- Buy Morgan Sindall Group (MGNS) by Deutsche Bank
- Hold GSK (GSK) by Deutsche Bank
- Overweight Unilever (ULVR) by Barclays
- Buy Morgan Sindall Group (MGNS) by Berenberg
- Outperform Rathbones Group (RAT) by RBC Capital
- Overweight Relx plc (REL) by Barclays
- Outperform Relx plc (REL) by Bernstein
Physiomics (PYC) Share Price
Health Care Sector
NOTE: This is based on 18 open tips for Physiomics (PYC)
| Latest Bid : 0.60p | Latest Ask : 0.70p |
| High Today : 0.80p | Low Today : 0.50p |
| This Years High : 0.80p | This Years Low : 0.26p |
| Volume : 29,781,448 | MKT Cap : £1.32M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000
Physiomics (PYC) Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.Physiomics (PYC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2023-05-23 16:00:00 23/05/2023 | 67.50% |
| Avoid | Steve Moore | Premium Only | 2023-04-26 15:55:00 26/04/2023 | 76.79% |
| Avoid | Steve Moore | Premium Only | 2023-04-04 12:50:00 04/04/2023 | 75.93% |
| Avoid | Steve Moore | Premium Only | 2022-10-12 11:35:00 12/10/2022 | 82.40% |
| Avoid | Steve Moore | Premium Only | 2022-10-04 13:45:00 04/10/2022 | 78.10% |
Physiomics (PYC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.60p | Latest Ask : 0.70p |
| High Today : 0.80p | Low Today : 0.50p |
| This Years High : 0.80p | This Years Low : 0.26p |
| Volume : 29,781,448 | MKT Cap : £1.32M |
Physiomics Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Physiomics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2023-05-23 16:00:00 23/05/2023 | 67.50% |
| Avoid | Steve Moore | Premium Only | 2023-04-26 15:55:00 26/04/2023 | 76.79% |
| Avoid | Steve Moore | Premium Only | 2023-04-04 12:50:00 04/04/2023 | 75.93% |
| Avoid | Steve Moore | Premium Only | 2022-10-12 11:35:00 12/10/2022 | 82.40% |
| Avoid | Steve Moore | Premium Only | 2022-10-04 13:45:00 04/10/2022 | 78.10% |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000